ã§çµç¹ã»å¥çŽäŸ¡æ Œãã芧ãã ããã
ãµã€ãºãéžæããŠãã ãã
衚瀺ã倿Žãã
ãã®ååã«ã€ããŠ
UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Conjugate:
unconjugated
Clone:
8A11.2, monoclonal
Application:
ICC, IF, IHC, WB
Citations:
3
ãã¯ãã«ã«ãµãŒãã¹
ãå°ãã®ããšãããã°ãçµéšè±å¯ãªãã¯ãã«ã«ãµãŒãã¹ããŒã ãã客æ§ããµããŒãããŸãã
ãæäŒãããŸãbiological source
mouse
Quality Segment
conjugate
unconjugated
antibody form
purified immunoglobulin
antibody product type
primary antibodies
clone
8A11.2, monoclonal
species reactivity
rabbit, rat, human, guinea pig
technique(s)
immunocytochemistry: suitable, immunofluorescence: suitable, immunohistochemistry: suitable, western blot: suitable
isotype
IgG2aκ
NCBI accession no.
UniProt accession no.
shipped in
wet ice
target post-translational modification
unmodified
Gene Information
human ... GJC1(10052)
General description
ã³ããã·ã³45ã¯ãã³ããã·ã³éºäŒåãã¡ããªãŒãšããŠç¥ãããã®ã£ããçµåã¿ã³ãã¯è³ªãã¡ããªãŒã®ã¡ã³ããŒã§ããçºçæããæäœãŸã§ãããŸããŸãªã¿ã€ãã®çްèã§çºçŸããŠãããç¹ã«å¿ççµç¹ãå¹³æ»ççµç¹ãè³çµç¹ã§çºçŸããŠããŸããã³ããã·ã³45ã¯ã现èãã现èãžäœååç©è³ªãæ¡æ£ãããçµè·¯ãšãªã现èéãã£ãã«ã®ãããã¯ãŒã¯ã®äžéšã圢æããŠããŸããã¹ãã©ã€ã·ã³ã°ããã転åç£ç©ã®å€ç°åã倿°ååšããŸããããããã¯ãã¹ãŠåãã¿ã³ãã¯è³ªã¢ã€ãœãã©ãŒã ãã³ãŒãããŠãããšèããããŠããŸãã
宿ž¬å€ïŒçŽ45 kDa
ã©ã€ã»ãŒãã«ãã£ãŠã¯ãããã«æããã«ãããŠããªããã³ããã¿ãããããšããããŸãã
ã©ã€ã»ãŒãã«ãã£ãŠã¯ãããã«æããã«ãããŠããªããã³ããã¿ãããããšããããŸãã
Immunogen
ããã³ããã·ã³45ã«çžåœããKLHçµåçŽéãããã
Application
ãã®æã³ããã·ã³45æäœCæ«ç«¯è¿åã现è質ãã¯ããŒã³8A11.2ïŒè
¹æ°Žäžå«ïŒã¯ãã³ããã·ã³45ã®æ€åºã«ãããŠããŠã§ã¹ã¿ã³ããããã£ã³ã°ãå
ç«çްèæè²ãå
ç«èå
æè²ãå
ç«çµç¹æè²ã§ã®äœ¿çšãæ€èšŒãããŠããŸãã
å
ç«çްèæè²ïŒãã©ã³ã¹ãã§ã¯ãããã©ããC6现èã§ã³ããã·ã³45ãæ€åºããŸããã
å ç«çްèæè²ïŒã©ãã倧åèå ç®çްèããã³ãã©ã³ã¹ãã§ã¯ãHeLa现èã§ã³ããã·ã³45ãæ€åºãããŸããïŒSorensen, C.M., et al. (2008) Am J Physiol Regul Integr Comp Physiol.295:R840âR847ïŒã
å ç«èå æè²ïŒHeLa现èããã³ããå¿ç现èã§ã³ããã·ã³45ãæ€åºããŸããïŒHagen, A., et al. (2009) Cardiovascular Research.83:405â415ïŒã
å ç«èå æè²ïŒæ£åžžã©ããæäœèè±ã§ã³ããã·ã³45ãæ€åºããŸããïŒIkeda Y., et al. (2007) Am J Physiol Renal Physiol.293(4):F1018âF1025ïŒã
ãŠã§ã¹ã¿ã³ããããã£ã³ã°ïŒHeLa现èããã³ããå¿ç现èã©ã€ã»ãŒãã§ã³ããã·ã³45ãæ€åºããŸããïŒHagen, A., et al. (2009) Cardiovascular Research.83:405â415ïŒã
ãŠã§ã¹ã¿ã³ããããã£ã³ã°ïŒã¢ã«ã¢ããã®å¿æ¿ãšæŽæ¿çµç¯çµç¹ã§ã³ããã·ã³45ãæ€åºããŸããïŒJones S.A., et al. (2004) The Journal of Physiology, 560:429-437ïŒ
ãŠã§ã¹ã¿ã³ããããã£ã³ã°ïŒéçåããã³ãã©ã³ã¹ãã§ã¯ãããHeLa现èã©ã€ã»ãŒãã§ã³ããã·ã³45ãæ€åºããŸããïŒElenes S., et al. (2001) Biophys J. 81(3):1406-18ïŒ
å ç«çµç¹æè²ïŒ æ¯åšçµç¹ã«ãããç¯æ£æ²»ç4æ¥åŸã®12æ¥éœ¢èå ã®ç¥çµç®¡ãšéªšé«è ããã³è¡ç®¡ã§ã³ããã·ã³45ãæ€åºãããŸããïŒGluhak-Heinrich, J., et al. (2006) Cell Commun Adhes.13(1-2):115â125ïŒã
å ç«çµç¹æè²ïŒ ãŠãµã®è žéªšåèã®å ç®ããã³å èäžå¹³æ»çã®ã£ããçµåãã©ãŒã¯ã«ãããŠãã³ããã·ã³45ãæ€åºãããŸããïŒChaytor, A.T., et al. (2005) British Journal of Pharmacology.144:108â114ïŒã
å ç«çµç¹æè²ïŒ ãŠãµã®ã®äžå€§è³åèã§ã³ããã·ã³45ãæ€åºããŸããïŒUjiie H., et al. (2003) Stroke.34(2):544-50ïŒã
å ç«çްèæè²ïŒã©ãã倧åèå ç®çްèããã³ãã©ã³ã¹ãã§ã¯ãHeLa现èã§ã³ããã·ã³45ãæ€åºãããŸããïŒSorensen, C.M., et al. (2008) Am J Physiol Regul Integr Comp Physiol.295:R840âR847ïŒã
å ç«èå æè²ïŒHeLa现èããã³ããå¿ç现èã§ã³ããã·ã³45ãæ€åºããŸããïŒHagen, A., et al. (2009) Cardiovascular Research.83:405â415ïŒã
å ç«èå æè²ïŒæ£åžžã©ããæäœèè±ã§ã³ããã·ã³45ãæ€åºããŸããïŒIkeda Y., et al. (2007) Am J Physiol Renal Physiol.293(4):F1018âF1025ïŒã
ãŠã§ã¹ã¿ã³ããããã£ã³ã°ïŒHeLa现èããã³ããå¿ç现èã©ã€ã»ãŒãã§ã³ããã·ã³45ãæ€åºããŸããïŒHagen, A., et al. (2009) Cardiovascular Research.83:405â415ïŒã
ãŠã§ã¹ã¿ã³ããããã£ã³ã°ïŒã¢ã«ã¢ããã®å¿æ¿ãšæŽæ¿çµç¯çµç¹ã§ã³ããã·ã³45ãæ€åºããŸããïŒJones S.A., et al. (2004) The Journal of Physiology, 560:429-437ïŒ
ãŠã§ã¹ã¿ã³ããããã£ã³ã°ïŒéçåããã³ãã©ã³ã¹ãã§ã¯ãããHeLa现èã©ã€ã»ãŒãã§ã³ããã·ã³45ãæ€åºããŸããïŒElenes S., et al. (2001) Biophys J. 81(3):1406-18ïŒ
å ç«çµç¹æè²ïŒ æ¯åšçµç¹ã«ãããç¯æ£æ²»ç4æ¥åŸã®12æ¥éœ¢èå ã®ç¥çµç®¡ãšéªšé«è ããã³è¡ç®¡ã§ã³ããã·ã³45ãæ€åºãããŸããïŒGluhak-Heinrich, J., et al. (2006) Cell Commun Adhes.13(1-2):115â125ïŒã
å ç«çµç¹æè²ïŒ ãŠãµã®è žéªšåèã®å ç®ããã³å èäžå¹³æ»çã®ã£ããçµåãã©ãŒã¯ã«ãããŠãã³ããã·ã³45ãæ€åºãããŸããïŒChaytor, A.T., et al. (2005) British Journal of Pharmacology.144:108â114ïŒã
å ç«çµç¹æè²ïŒ ãŠãµã®ã®äžå€§è³åèã§ã³ããã·ã³45ãæ€åºããŸããïŒUjiie H., et al. (2003) Stroke.34(2):544-50ïŒã
ç ç©¶ã«ããŽãªãŒ
çŽ°èæ§é
çŽ°èæ§é
ç ç©¶ãµãã«ããŽãªãŒ
å忥çïŒCAMïŒ
å忥çïŒCAMïŒ
Physical form
ãã©ãŒãããïŒç²Ÿè£œ
粟補ãããã€ã³G
粟補ããŠã¹ã¢ãã¯ããŒãã«IgG2aκæäœã0.1 M Tris-ã°ãªã·ã³ãããã¡ãŒïŒpH 7.4ïŒïŒ150 mM NaCl溶液ã0.05%ã¢ãžåãããªãŠã 嫿
Preparation Note
2ïœ8°Cã§åé æ¥ãã1幎éå®å®ã§ãã
Analysis Note
U2OS现èã©ã€ã»ãŒãã«ãããŠãŠã§ã¹ã¿ã³ããããã£ã³ã°ã«ããè©äŸ¡ãããŠããŸãã
ãŠã§ã¹ã¿ã³ããããã£ã³ã°ïŒ0.5 µg/mLã§äœ¿çšã10µgã®U2OS现èã©ã€ã»ãŒãäžã®ã³ããã·ã³45ãæ€åºã§ããŸãã
ãŠã§ã¹ã¿ã³ããããã£ã³ã°ïŒ0.5 µg/mLã§äœ¿çšã10µgã®U2OS现èã©ã€ã»ãŒãäžã®ã³ããã·ã³45ãæ€åºã§ããŸãã
Other Notes
å
çºåïŒMABC3100
æ¿åºŠïŒãããã«åºæã®ããŒã¿ã·ãŒããåç
§ããŠãã ããã
Disclaimer
ã¡ã«ã¯ã®ã«ã¿ãã°ãŸãã¯è£œåã«æ·»ä»ãããã¡ã«ã¯ã®ãã®ä»ã®ææžã«èšèŒãããŠããªãå Žåãã¡ã«ã¯ã®è£œåã¯ç ç©¶çšéã®ã¿ãç®çãšããŠãããããä»ã®ãããªãç®çã«ã䜿çšããããšã¯ã§ããŸããããã®ãããªç®çãšããŠã¯ãæªæ¿èªã®åæ¥çšéãin vitroã®èšºæçšéãex vivoãããã¯in vivoã®æ²»ççšéããŸãã¯ãããããã¯åç©ãžã®ããããçš®é¡ã®æ¶è²»ãããã¯é©çšãªã©ããããŸããããããã«éå®ãããŸããã
Still not finding the right product?
補åéžæããŒã«}ã§éžæè¢ãçµã蟌ãã§ãã ããã
ä¿ç®¡åé¡
12 - Non Combustible Liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
è©ŠéšæçžŸæžïŒCOAïŒ
補åã®ãããçªå·ã»ãããçªå·ãå ¥åããŠãè©ŠéšæçžŸæžïŒCOAïŒ ãæ€çŽ¢ã§ããŸãããããçªå·ã»ãããçªå·ã¯ã補åã©ãã«ã«ãLotããŸãã¯ãBatchãã«ç¶ããŠèšèŒãããŠããŸãã
以åãã®è£œåãè³Œå ¥ããã ããããšãããå Žå
ææžã©ã€ãã©ãªã§ãæè¿è³Œå ¥ãã補åã®ææžãæ€çŽ¢ã§ããŸãã